Bharat Immunological & Biological Corporation Ltd

BSE : Bharat_Immunolog23 Jan 2025

Pharmaceuticals

₹

+0.43 (+1.69%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd

Pharmaceuticals

BSE : Bharat_Immunolog23 Jan 2025

₹

+0.43 (+1.69%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
07-Aug-2024	BC	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant	16-Aug-2024
29-Feb-2024	BC	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant	08-Mar-2024
28-Nov-2023	BC	Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please. Intimation of Book Closure in respect of AGM	29-Dec-2023
28-Nov-2023	BC	Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please. Intimation of Book Closure in respect of AGM	22-Dec-2023
19-Oct-2023	BC	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Pursuant	31-Oct-2023

No Rights has been declared by Bharat_Immunolog

Book Closure

Record Date	Split Date	Purpose
16-Aug-2024	-	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant
08-Mar-2024	-	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant
29-Dec-2023	-	Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please. Intimation of Book Closure in respect of AGM
22-Dec-2023	01 Jan'1900	Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please. Intimation of Book Closure in respect of AGM
31-Oct-2023	-	BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Pursuant

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Bharat Immunological & Biological Corporation Ltd ₹25.86(+0.43/1.69%)	25.86	+0.43	111.66	-21.37	0.00	-3.43
Bliss GVS Pharma Ltd ₹164.60(-1.10/-0.66%)	164.60	-1.10	1,734.33	35.21	21.46	1.69
Amrutanjan Health Care Ltd ₹699.70(+9.25/1.34%)	699.70	+9.25	2,022.88	16.55	42.56	6.79
Astrazeneca Pharma India Ltd ₹7,073.20(+105.80/1.52%)	7,073.20	+105.80	17,683.00	10.43	137.37	26.03
Abbott India Ltd ₹27,838.35(+92.40/0.33%)	27,838.35	+92.40	59,156.49	9.02	46.05	16.80
Ambalal Sarabhai Enterprises Ltd ₹49.82(+0.66/1.34%)	49.82	+0.66	381.79	2.61	43.32	8.47

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	4.64	1.23	0.99	0.41	1.20
Net Cash from Operating Activities	10.89	-42.12	11.78	34.08	-32.10
Net Cash Used In Investing Activities	0.46	0.53	0.67	0.91	0.70
Net Cash Used In Financing Activities	-14.71	45.00	-12.20	-34.41	30.61
Net Inc./Dec In Cash And Cash Equivalents	-3.36	3.42	0.24	0.58	-0.79
Cash And Cash Equivalents At End Of The Year	1.29	4.64	1.23	0.99	0.41

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

59.25%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

40.75%

**Promoter pledged shareholding 59.25%

About Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 111.66 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -4.92 crores for the quarter ended December 2018. The company management includes Y K Gupta, Y K Gupta,Sandip K Lal,Alka Sharma,Mohd Aslam,Sudhanshu Vrati,Madhu Dikshit,Sanjay Kumar Mishra,Pankaj Kumar (Bharat Immunological & Biological Corporation Ltd) among others.

Chairman

Y K Gupta

Registered office

BIBCOL OPV Plant Village Chola,,Bulandshahr,Uttar Pradesh,203203

FAX :

Background

Incorporation Year1989

Face Value₹10

Market Lot1